Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.
Seres Therapeutics has raised $3.6M in total funding. The most recent round was Grant. The last funding was announced in October 2025.
Seres Therapeutics's investors include RA Capital Management, Mayo Clinic, Oaktree Capital Management, Sofinnova Investments, Flagship Pioneering.
Seres Therapeutics is headquartered in Cambridge, United States.
Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.
Seres Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Seres Therapeutics — Funding & Investors." VCBacked, October 29, 2025, https://www.vcbacked.co/company/seres-therapeutics. Accessed July 19, 2026.
VCBacked. (2025). Seres Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/seres-therapeutics
{{cite web |title=Seres Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/seres-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated